RPG Life Sciences Limited
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. … Read more
RPG Life Sciences Limited - Asset Resilience Ratio
RPG Life Sciences Limited (RPGLIFE) has an Asset Resilience Ratio of 31.67% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2025)
This chart shows how RPG Life Sciences Limited's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down RPG Life Sciences Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹1.32 Billion | 18.68% |
| Short-term Investments | ₹917.20 Million | 13.0% |
| Total Liquid Assets | ₹2.24 Billion | 31.67% |
Asset Resilience Insights
- Very High Liquidity: RPG Life Sciences Limited maintains exceptional liquid asset reserves at 31.67% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
RPG Life Sciences Limited Industry Peers by Asset Resilience Ratio
Compare RPG Life Sciences Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF |
Drug Manufacturers - Specialty & Generic | -0.02% |
|
Kamada
NASDAQ:KMDA |
Drug Manufacturers - Specialty & Generic | 21.63% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
|
Yuyu Pharma Inc
KO:000227 |
Drug Manufacturers - Specialty & Generic | 1.74% |
Annual Asset Resilience Ratio for RPG Life Sciences Limited (2017–2025)
The table below shows the annual Asset Resilience Ratio data for RPG Life Sciences Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 39.81% | ₹2.62 Billion | ₹6.58 Billion | +15.80pp |
| 2024-03-31 | 24.01% | ₹1.23 Billion | ₹5.13 Billion | -5.13pp |
| 2023-03-31 | 29.14% | ₹1.22 Billion | ₹4.19 Billion | +25.41pp |
| 2022-03-31 | 3.73% | ₹128.60 Million | ₹3.45 Billion | +3.23pp |
| 2021-03-31 | 0.50% | ₹15.30 Million | ₹3.03 Billion | +0.46pp |
| 2020-03-31 | 0.04% | ₹1.20 Million | ₹2.67 Billion | 0.00pp |
| 2019-03-31 | 0.05% | ₹1.20 Million | ₹2.51 Billion | -0.24pp |
| 2018-03-31 | 0.28% | ₹8.30 Million | ₹2.91 Billion | +0.08pp |
| 2017-03-31 | 0.20% | ₹5.00 Million | ₹2.46 Billion | -- |